Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug

Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp



The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.

Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp

Never miss any important news. Subscribe to our newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *